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The mouse aldehyde oxidase AOH2 (aldehyde oxidase homolog 2) is a molybdoflavoenzyme. Harderian
glands are the richest source of AOH2, although the protein is detectable also in sebaceous glands, epidermis,
and other keratinized epithelia. The levels of AOH2 in the Harderian gland and skin are controlled by genetic
background, being maximal in CD1 and C57BL/6 and minimal in DBA/2, CBA, and 129/Sv strains. Testos-
terone is a negative regulator of AOH2 in Harderian glands. Purified AOH2 oxidizes retinaldehyde into
retinoic acid, while it is devoid of pyridoxal-oxidizing activity. Aoh2/ mice, the first aldehyde oxidase
knockout animals ever generated, are viable and fertile. The data obtained for this knockout model indicate a
significant role of AOH2 in the local synthesis and biodisposition of endogenous retinoids in the Harderian
gland and skin. The Harderian gland’s transcriptome of knockout mice demonstrates overall downregulation
of direct retinoid-dependent genes as well as perturbations in pathways controlling lipid homeostasis and
cellular secretion, particularly in sexually immature animals. The skin of knockout mice is characterized by
thickening of the epidermis in basal conditions and after UV light exposure. This has correlates in the
corresponding transcriptome, which shows enrichment and overall upregulation of genes involved in hyper-
trophic responses.
Aldehyde oxidases (AOXs) (EC 1.2.3.1) are structurally
conserved proteins belonging to the family of molybdoflavoen-
zymes along with xanthine oxidoreductase (XOR), the key
enzyme in the catabolism of purines (25, 28). In their catalyt-
ically active form, both AOXs and XORs are dimers of iden-
tical subunits characterized by three conserved domains sepa-
rated by nonconserved hinge regions (28). The amino-terminal
25-kDa domain contains two nonidentical 2Fe-2S redox cen-
ters. The flavin adenine dinucleotide binding region is located
in the intermediate 45-kDa domain, while the substrate and
the molybdopterin cofactor binding pocket reside in the car-
boxy-terminal 85-kDa domain (28). AOXs have broad sub-
strate specificity, hydroxylating N-heterocycles or oxidizing al-
iphatic as well as aromatic aldehydes into the corresponding
acids (35, 41, 42).
The primary structures of mammalian AOXs and XORs are
more than 40% identical, and the two types of enzymes are
evolutionary related. Most of the available data indicate that
AOXs evolved from a primordial form of XOR through a
series of gene duplication events (28). In mammals, the num-
ber of AOX genes is variable and species specific (25, 28, 37,
65). Rodents have four AOX genes (Aox1, Aoh1, Aoh2, and
Aoh3) which are the products of asynchronous duplication
events and cluster at a short distance from one another on the
same chromosome (chromosome 1c1 in mice and chromosome
9 in rats) (Fig. 1). The Aoh1, Aoh2, and Aoh3 genes are also
known as Aox3, Aox4, and Aox3l, respectively, and are cur-
rently designated with the latter names in the NCBI database.
(The designation of the four mouse AOX genes as Aox1, Aox3,
Aox4, and Aox3l in the NCBI database is still provisional. As
discussed in the work of Garattini et al. [25], the gene names
adopted in the NCBI database are confusing. For this reason,
we decided to adopt our original nomenclature throughout the
text and refer hereafter to the four mouse AOX genes as Aox1,
Aoh1, Aoh2, and Aoh3). The four loci code for equivalent
numbers of structurally related products, which represent
AOX isoenzymatic forms. The dog has two functional genes,
the orthologs of rodent Aoh2 and Aoh3, and two pseudogenes
showing high similarity with Aox1 and Aoh1 (25). Finally, the
human genome is endowed with a single functional gene
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(AOX1) and two pseuodogenes representing the vestiges of the
mouse and rat Aoh1 and Aoh3 loci (28) (Fig. 1), all mapping to
chromosome 2q (13, 28, 66).
Great amounts of human AOX1 as well as rodent AOX1
and AOX homolog 1 (AOH1) proteins are synthesized in liver
and lung (2, 36, 46, 65–68), although cell-specific expression of
these enzymes in other organs and tissues, such as the central
nervous system, is observed (12, 13). Most of the data available
on the function of these enzymes relate to hepatic AOXs and
AOX1 in particular. This protein is a well-known drug-metab-
olizing enzyme, oxidizing various xenobiotics of medical and
toxicological importance (6–11, 48–50, 53, 54). Expression of
the Aoh3 gene is restricted to the Bowman’s gland, the main
secretory organ of the nasal mucosa. The protein has been
purified to homogeneity from this source and shown to have an
overlapping set of substrates with AOX1 and AOH1 (31). No
information is available on the product of the mouse Aoh2
gene, whose protein has never been isolated. AOH2 ortholo-
gous proteins are predicted to exist in rats, marsupials, dogs,
horses, and cows. It is possible that a functionally active Aoh2
ortholog is also present in Old World monkeys, such as Macaca
(M. Terao and E. Garattini, unpublished observations), al-
though a similar gene is not found in chimpanzee and human
genomes. The lack of Aoh2 orthologs suggests a species-spe-
cific function that became dispensable in some primates and
humans (23).
The physiological substrates of vertebrate AOXs are un-
known, which makes it difficult to postulate a function for the
enzymes. In vitro, all-trans retinaldehyde (RAL), the precursor
of all-trans retinoic acid (ATRA), the active metabolite of
vitamin A, is a good substrate for rat and mouse AOX1,
AOH1, and AOH3. Other postulated endogenous substrates
for AOXs are nicotinamide, pyridoxal, and serotonin oxidation
metabolites (25). Finally, AOX activities have been implicated
in the catabolism of the amino acids, isoleucine, leucine and
valine (KEGG; http://www.kegg.jp).
The present article provides novel information on the tissue
and cell distribution of the mouse AOH2 protein, demonstrat-
ing selective localization in the Harderian glands (HGs) and
sebaceous glands as well as in keratinized epithelia. Purifica-
tion and characterization of AOH2 demonstrate that the pro-
tein oxidizes RAL into ATRA with high affinity and efficiency.
However, unlike AOH1 and AOX1 from different animals,
mouse AOH2 is devoid of pyridoxal-oxidizing activity. Func-
tional inactivation of the Aoh2 gene by homologous recombi-
nation and generation of a knockout animal (Aoh2/ mouse)
demonstrates a deficiency of ATRA synthesis in both the HG
and skin. This is accompanied by alterations in the phenotypes
and transcriptomes of the two organs.
MATERIALS AND METHODS
Animals and treatments. Animals with different genetic backgrounds, namely,
CD1, BDF1, C57BL/6, BDA/2, and 129/Sv, were purchased from Charles River
Laboratories (Calco, Italy). Animals were maintained on standard chow and
colonies expanded in standard-pathogen-free animal house facilities. All the
procedures involving animals were performed according to the relevant national
and international legislation and authorized by the internal Ethical Committee of
the Animal Care Unit. Testosterone treatments were performed as described in
a previous publication (36). To evaluate photodamage to the skin, female ani-
mals were shaved on the back and treated with UVB, using a light bulb placed
at a 25-cm distance from the dorsal areas of the animal. Treatment consisted of
a daily 30-min period of irradiation of anesthetized animals for 4 days. One hour
after the last treatment, animals were sacrificed and extracted tissues were kept
frozen until use. Tissue samples for the measurement of retinoids were prepared
with minimal exposure to light.
Morphometric analysis of the skin. Four experimental groups were used for
these studies: mock- and UV-treated wild-type (WT) and Aoh2/ animals.
Biopsy punches (8 mm in diameter) were obtained from the central part of the
dorsal skin by use of a disposable apparatus (Stiefel Laboratories SRL, Milan,
Italy). The biopsy samples were fixed in 4% paraformaldehyde and paraffin
embedded and tissue sections were prepared according to standard protocols.
FIG. 1. The mouse and human AOX gene clusters and XOR locus. (Top) The lengths and relative positions of the four mouse AOX genes
(Aox1, Aoh1, Aoh2, and Aoh3) mapping to chromosome 1 and the single XOR gene (Xor) on chromosome 17, along with their exon composition,
are illustrated. (Bottom) The lengths and relative positions of the only functionally active human AOX gene (AOX1), the two pseudogenes AOH1*
and AOH3* on chromosome 2q, and the XOR gene on chromosome 2p are shown. The exons present in the active mouse and human genes are
indicated. The exons showing sequence similarity with the corresponding mouse orthologous genes are indicated above the two human pseudo-
genes. Chr, chromosome.
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Five fields for each histological section (five slides per animal; four animals per
experimental group) were randomly selected and the epidermal thickness was
evaluated under the microscope (magnification, 400). The epidermal thickness
was expressed as the linear distance between the basal membrane and the apical
portion of the last epithelial layer by use of an automatic image acquisition
instrument (Image Pro Plus 4.5; Media Cybernetics). The minimal, maximal,
mean, and median thicknesses of the epidermis were measured.
Generation of knockout mice. To prepare the targeting construct, a 1.3-kb
EcoRI/NsiI genomic fragment derived from Aoh2 intron 21 was cut from the
PAC3 clone (67) and subcloned into the EcoRI/PstI sites of pBluescript (Strat-
agene, La Jolla, CA), and plasmid pB1.3 was obtained. A 4.3-kb HindIII/BamHI
genomic fragment consisting of Aoh2 exons 23 to 26 and corresponding introns
was subcloned into the HindIII/BamHI sites of pBluescript, and plasmid pB4.3
was obtained. Plasmid pB1.3 was digested with EcoRI/BamHI and inserted in the
corresponding sites of the pPNT vector (47), and plasmid pPNT1.3 was obtained.
The 4.3-kb Aoh2 fragment contained in pB4.3 was isolated by cleavage with
XhoI/NotI and inserted in the corresponding sites of pPNT1.3, generating the
entire targeting cassette. In this cassette, exon 22 was replaced by the neomycin
resistance gene, the original NsiI and ScaI sites were eliminated, and a new XbaI
site was derived from vector sequences.
The targeting vector was linearized by NotI digestion and electroporated in
AB1 (129/Sv EvBrd Hprt, kindly provided by Alan Bradley) embryonic stem
(ES) cells according to standard procedures (33). Out of the 423 clones that were
selected in the presence of the antibiotics G418 (Geneticin; Clontech, Palo Alto,
CA) and FIAU (2-fluoro-2-deoxy-1--D-arabinofuranosyl-5-iodouracil; a kind
gift from Eli-Lilly, Indianapolis, IN), only one clone, named 5E7, carried the
homologous recombination event, as assessed by PCR and Southern blot anal-
yses. Chimeric mice were generated by injection of 5E7 cells in the blastocoel
cavity of 3.5-day BDF1 embryos (F1 hybrids; C57BL/6  DBA/2) (44). Upon
maturity, chimeric animals bearing agouti hair were mated to C57BL/6 females,
resulting in heterozygous animals with germ line transmission of the trait. Het-
erozygous Aoh2 knockout mice were consecutively mated with C57BL/6 mice for
nine generations to obtain an AOH2-deficient mouse line with a pure C57BL/6
background. The homogeneity of the background was confirmed by microsatel-
lite analysis of the genome. Unless otherwise specified in the text, all the WT and
knockout animals used for experiments were stabilized on the C57BL/6 genetic
background.
Western blot analysis and in situ hybridization. Western blot analyses were
performed as previously described using a chemiluminescence-based protocol
(37, 68). The specific anti-AOX1, anti-AOH1, anti-AOH2, and anti-AOH3 rab-
bit polyclonal antibodies have also been described previously (37, 68). For the in
situ hybridization experiments, a PCR-amplified fragment of AOH2 cDNA (nu-
cleotides 4169 to 4787) was subcloned in pBluescript and used as the template for
the synthesis of the sense and antisense riboprobes, employing T3 and T7 RNA
polymerases (Stratagene), in the presence of 35S-labeled thio-UTP (specific
radioactivity, 1,200 Ci/mmol; GE Healthcare, Milan, Italy). Manipulation and
hybridization of the probes to tissue sections were as described previously (68).
Tissue sections were stained with hematoxylin-eosin and photographed under
the microscope.
Measurements of RAL-oxidizing activity. RAL-oxidizing activity was deter-
mined in 100 l of 10 mM of potassium phosphate buffer (pH 7.4) containing 15
to 100 g of cytosolic protein extracts and 0.05 mM RAL, in the presence or
absence of 2 mM NAD after incubation at 37°C for 10 min in the dark. The
reaction was terminated by the addition of an equal volume of 95% butanol-5%
methanol containing 0.005% butylated hydroxytoluene and centrifuged, and the
supernatants were subjected to high-performance liquid chromatography
(HPLC) analysis using a C18 reverse-phase column (70) or to mass spectrometric
(MS) analysis (see Table S1 in the supplemental material).
Purification of mouse AOH2 protein, electrophoresis, and spectroscopy. Un-
less otherwise stated, all the purification steps were carried out at 4°C. HGs from
100 male mice (3.4 g) were homogenized in 8 volumes of 100 mM sodium
phosphate buffer, pH 7.5, containing 0.2 mM phenylmethylsulfonyl fluoride, 1
g/ml each of aprotinin and leupeptin, and 0.1 mg of soybean trypsin inhibitor,
with an Ultraturrax homogenizer (IKA Werke GmbH, Staufen, Germany). Ho-
mogenates were centrifuged at 105,000  g for 45 min to obtain cytosolic
extracts. Extracts were heated at 55°C for 10 min and centrifuged at 15,000  g
to remove precipitated proteins. An equal volume of saturated ammonium sul-
fate was added to the supernatant, and the precipitate was collected by centrif-
ugation at 15,000  g and resuspended in 100 mM Tris-glycine buffer, pH 9.0.
Solubilized proteins were mixed with 5 ml of benzamidine-Sepharose (Amer-
sham Pharmacia Biotech, Uppsala, Sweden) preequilibrated in 100 mM Tris-
glycine buffer, pH 9.0. Following 2 h of incubation, the resin was washed four
times, each with 10 ml of the equilibration buffer to remove unbound proteins.
Adsorbed proteins were eluted twice with 5-ml aliquots of equilibration buffer
containing 5 mM benzamidine (Sigma Chemical Co., St. Louis, MO). The eluate
was concentrated to 1 ml with Centriplus YM-100 (Millipore Corp., Bedford,
MA) and diluted to 10 ml with 50 mM Tris-HCl, pH 7.4. The solution was
applied to a 5/5 fast protein liquid chromatography MonoQ (GE Healthcare)
equilibrated in 50 mM Tris-HCl, pH 7.4. The AOH2 protein was eluted at 0.5
ml/min with a linear gradient (30 ml) from 0 to 1 M NaCl in 50 mM Tris-HCl,
pH 7.4. The purification of AOH2 was monitored by determination of RAL-
oxidizing activity and by quantitative Western blot analysis (37). One unit of
enzymatic activity corresponds to 1 nmol of RAL oxidized/min. The absorbance
spectrum of AOH2 in its native state was recorded at 20°C with a Hewlett-
Packard HP8453 diode array spectrophotometer interfaced with a Vectra XA
personal computer (Hewlett-Packard, Palo Alto, CA).
MS of the purified AOH2 protein. Electrospray ionization-tandem MS anal-
yses of AOH2 tryptic peptides were performed according to standard protocols
following in situ or in gel tryptic digestion using a Bruker Biflex matrix-assisted
laser desorption ionization–time of flight (MALDI-TOF) MS (Bruker, Bremen,
Germany) (37). Data generated were processed with the Mascot program (http:
//www.matrixscience.com) allowing a mass tolerance of 0.4 Da. Direct sequence
analysis was carried out via collision-induced dissociation (CID) on an electro-
spray MS API 3000 (Applied Biosystems, San Diego, CA). The program MS-Tag
(http://prospector.ucsf.edu) was used to correlate the experimental CID spectra
to the theoretical CID spectra of tryptic peptides derived from proteins present
in databases.
Whole-genome gene expression microarrays: collection of samples, experi-
mental design, and analysis. For the studies involving HGs, WT and Aoh2/
animals were divided into four groups: males and females before and after sexual
maturation (5 to 6 and 7 to 9 weeks, respectively). Whole HGs were dissected
without any contamination of surrounding tissues. At least three pairs of animals
(WT and Aoh2/) for each experimental group were used for the extraction of
total RNA. When possible, each pair of age- and sex-matched RNA samples
from WT and Aoh2/ mice was obtained from siblings of the same heterozy-
gous mating. Couples of samples were hybridized on the same slide, in dye-
swapped duplicates, for a total of 30 microarrays. For the studies involving skin,
equivalent biopsy samples (8 mm in diameter) of the dorsal areas of four WT and
four Aoh2/ female mice were obtained and processed for the extraction of
RNA. Age-matched pairs of samples obtained from the same mating were
hybridized on the same slide with a balanced dye design, for a total of eight
microarrays.
All the experiments were performed with commercially available mouse gene
expression microarrays consisting of approximately 44,000 probes (whole-mouse-
genome microarray kit, 44,000 for the HG and 4  44,000 for the skin; Agilent,
Palo Alto, CA). Total RNA was extracted using Qiagen RNeasy columns (Qia-
gen SpA, Milan, Italy). RNA (1 g) was labeled with Cy3 or Cy5 by use of a
commercially available kit (amino allyl message AmpII aRNA amplification kit;
Ambion Inc., Austin, TX).
Microarray slides were scanned with an Agilent scanner, and image data were
analyzed using the Feature Extraction software (Agilent, version 9.1). Due to the
high variability between the Aoh2/ and WT log ratios, we decided to perform
variance stabilization normalization (VSN) (29). Two-way analysis of variance
(ANOVA) was performed, with Aoh2/ versus WT as the first factor and the
four animal groups as the second factor. A total of 3,977 probes showed a P value
of less than 0.005 for at least one of the factors or for their interaction. This
corresponds to a false-discovery rate of 5.5%. From this list we removed replicate
probes or probes for the same genes according to the following criteria: (i) a
preference for probes with lower P values; (ii) when differences in P values were
low, a preference for the probes significant for factor i; and (iii) a preference for
probes corresponding to NM-labeled reference sequences followed by XM-,
AK-, and BC-labeled sequences. This resulted in a list of 3,468 nonreplicate
genes that were used for the principal component analysis (PCA). PCA plots
provide a graphical representation of high-dimensional expression data in low
dimensions. Throughout the study, only two (normally the first two, sometimes
the third, when it was endowed with a better discriminating power) of the three
components that account for the highest variation are shown. The similarity
within a set of samples or experimental groups is indicated by physical proximity.
Gene set enrichment analysis (GSEA) was performed using the gene score
resampling method of the ErmineJ software (38). We performed the analysis
using the individual genes’ P values of the knockout versus WT factor in two-way
ANOVA. We obtained a list of 339 categories showing a P value of less than
0.001 (Benjamini Hochberg correction for multiple testing, corresponding to a
raw P value of 0.0001). Due to the inherent characteristics of the gene ontology
(GO) annotation, the list is highly redundant. Therefore, we selected the most
informative categories according to the following criteria: (i) the smallest cate-
VOL. 29, 2009 Aoh2 KNOCKOUT MOUSE AND RETINOIC ACID SYNTHESIS 359
 at UNIV DEG
LI STUDI DI M
ILANO
 on M
arch 4, 2009 
m
cb.asm
.org
D
ow
nloaded from
 
gory with the highest P value, (ii) preference for biological process categories
over molecular function or cellular component, and (iii) selection of only one of
the categories pertaining to the same group of biological processes. We used the
same GSEA for two other gene categories that we considered important for our
study and were not adequately represented in the GO database, namely, genes
regulated by ATRA (5) and genes responsible for tissue hypertrophy (in the
“diseases” lists of Metacore; http://www.genego.com). For the enriched path-
ways, we determined the general direction of the changes, performing GSEA and
using log ratios rather than P values as scores. The same analysis was repeated
twice, giving the best score to the highest log ratio (prevalence of upregulation)
or, conversely, the best score to the lowest log ratio (prevalence of downregu-
lation). We considered that there was a general downregulation if only down-
regulation analysis resulted in a significant difference (P  0.05) or if there was
a difference between downregulation and upregulation P values of more than 4
orders of magnitude.
The results of the microarray experiments performed on skin samples were
normalized in two ways: (i) lowess normalization of the individual log ratios for
the differential regulation analysis, and (ii) VSN for the comparison with the HG
and for the PCA of the genes belonging to specific categories. GSEA was
performed as described for the HG. After Benjamini Hochberg correction for
multiple testing (corresponding to a raw P value of 0.0001), we obtained a list of
160 categories showing P values of less than 0.002.
Measurement of RAL and ATRA by MS. Reference standards of RAL and
ATRA were from Sigma (St. Louis, MO). The internal standard (ST1926) is a
synthetic retinoid and was synthesized by Sigma-tau Industrie Farmaceutiche
Riunite S.p.A. (Pomezia, Italy). Stock solutions were made in acetonitrile at the
concentration of 1 mg/ml and stored at 20°C in the dark. Working solutions
containing all the substances to be analyzed were prepared before each analytical
run. Acetonitrile for LC-MS was from Riedel de Haen (Seelze, Germany) and
HPLC-grade Milli-Q water was obtained with a Milli-Ro Plus 90 apparatus
(Millipore, Molsheim, France). The methodological details of the analytical
procedure are described in Table S1 in the supplemental material.
Microarray data accession number. Further details on the design of the study
and the methodologies used can be found under accession number GSE12541 of the
GEO database, where the microarray data have been deposited (http://www.ncbi
.nlm.nih.gov/geo/query/acc.cgi?token 	 rfohdqgwiqyywvo&acc 	 GSE12541).
RESULTS
AOH2 tissue- and cell-specific expression profile: high levels
in the HGs and sebaceous glands with detectable levels in the
epidermis and other keratinized epithelia. In a first set of
experiments, we studied the tissue distribution of the AOH2
protein by Western blot analysis using an antipeptide poly-
clonal antibody devoid of cross-reactivity with other AOX
isoenzymes (37). As shown in Fig. 2A, large amounts of AOH2
are synthesized by the HG, the major intraorbital exocrine
gland located behind the ocular bulb. AOH2 is the only AOX
present in this organ. The protein comigrates with the corre-
sponding recombinant product expressed in HEK293T cells.
This is in line with an apparent molecular mass of approxi-
mately 150 kDa and is consistent with the size of the putative
monomeric subunit of mouse AOH2 (67, 68). The protein is
also detectable in the skin, the mucosal layer lining the oral
cavity (tongue) (Fig. 2B), and the esophagus (data not shown).
FIG. 2. Tissue- and cell-specific expression of the AOH2 protein and mRNA. (A, B, and C) Tissue and organ distribution of the AOH2 protein.
Extracts (100 g) of the indicated tissues and organs were loaded on an 8% polyacrylamide gel run in denaturing and reducing conditions,
transferred to nitrocellulose membranes, and subjected to Western blot analysis with anti-AOH2, anti-AOX1, anti-AOH1, anti-AOH3, and
anti--actin antibodies. Abbreviations: PG, preputial gland; SV, seminal vesicles; OM, olfactory mucosa; SG, salivary gland; SmG, submaxillary
gland; C	 extracts of HEK293 cells transfected with the full-length AOH2 cDNA used as a positive control for the experiment. (D) Tissue sections
derived from HGs (a and b) and skin (c to f) were hybridized to a 35S-radiolabeled AOH2 sense (a and c) or antisense (b, d, e, and f) riboprobes.
Magnifications, 200 (a and b), 100 (c and d), and 400 (e and f). Abbreviations: sbl, suprabasal layer; bl, basal layer; sg, sebaceous glands; M,
molecular mass.
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AOH2-negative tissues include kidney, adrenal gland, pan-
creas, hypophysis, brain, cerebellum, and spinal cord (data not
shown). As indicated by Fig. 2C, AOH2 must serve a specific
function in the HG, as the protein is not detectable in other
exocrine structures such as the preputial, extraorbital lacrimal
(data not shown), salivary, and submaxillary glands. The tissue
distributions of AOH2 and other AOX isoenzymes differ.
AOX1 and AOH1 are expressed predominantly in the liver
(67), whereas AOH3 is restricted to the Bowman’s gland in the
nasal mucosa (Fig. 2A) (37). A strict correlation between the
levels of AOH2 protein and corresponding mRNA is observed
for the HG, tongue, esophagus, and skin, as assessed by North-
ern blot or quantitative reverse transcription-PCR (RT-PCR)
analysis (data not shown).
The HG lays in close proximity with the intraorbital lacrimal
gland, from which it cannot be dissected. The two structures
can be recognized only at the microscopic level. The secretory
acini of the HG are characterized by porphyrin deposits and
lipid secretions inside the ductal lumen. In situ hybridization
experiments with a specific antisense AOH2 RNA probe dem-
onstrate that the corresponding transcript is expressed homo-
geneously and at high levels in the majority of the epithelial
cell population lining the ducts of the HG (Fig. 2D, panel b).
This is the predominant cell population present in the organ.
No accumulation of silver grains is observed in vicinal tissue
sections hybridized with the sense AOH2 RNA probe (Fig. 2D,
panel a).
Further in situ hybridization experiments performed with
the same AOH2 sense (Fig. 2D, panel c) and antisense (Fig.
2D, panel d) probes indicate that the low levels of AOH2
protein determined in the skin are the consequence of selective
synthesis of the corresponding RNA in two locations: the epi-
dermis and the sebaceous glands. Microphotographs of the
epidermis taken at higher magnification (Fig. 2D, panel e)
show that the AOH2 mRNA is synthesized only in the supra-
basal layer, which differentiates from the basal layer of cells.
This is similar to what observed for the keratinized epithelium
covering the tongue, the esophagus, and the first part of the
stomach (67). High-magnification pictures of the sebaceous
glands (Fig. 2D, panel f) show accumulation of silver grains in
the secretory epithelial cells, which are characterized by the
production of a lipid-rich secretion similar to that of the HG.
Control of AOH2 expression in the HG by genetic back-
ground and testosterone. Interindividual variations in the lev-
els of AOX have been reported for humans (25). Similarly,
there is evidence of variability in the amounts of hepatic AOX
activity in different mouse and rat strains via epigenetic mech-
anisms (25, 70). For mice, we observed epigenetic silencing of
the AOH1 gene in certain common strains (70). Furthermore,
mouse AOX1 and AOH1 show an expression profile which is
dimorphic and gender dependent (36), as males synthesize
larger amounts of hepatic AOX1 and AOH1 proteins than
females (36). To establish the existence of variations in the
expression of AOH2 in different animal strains, we considered
four types of mouse. The outbred CD1 and the inbred
C57BL/6 mice are proficient, while DBA/2 and CBA mice are
deficient for the expression of hepatic AOH1 in the liver (70).
In this study, we also included 129/Sv, since this is the strain of
origin of the ES cell line used for the generation of the Aoh2
knockout mice described below.
As expected, the HGs of C57BL/6 and CD1 mice are rich
sources of AOH2 (Fig. 3A). Furthermore, the two strains syn-
thesize detectable and equivalent amounts of the protein in the
skin (Fig. 2B and 3B). In contrast, the HGs and the skin of
DBA/2, CBA, and 129/Sv animals are devoid of AOH2 (Fig.
3A and B). Thus, DBA/2 and CBA strains have a general
deficit in the tissue-specific synthesis of AOXs involving not
only AOH1 and AOX1 but also AOH2. This is not the case for
129/Sv mice (64), which are not deficient in the expression of
hepatic AOH1 and AOX1 (70).
To define whether AOH2 is regulated in a sex-specific man-
ner by steroid hormones, we determined the steady-state levels
of the protein in the HGs of male and female animals during
the postnatal development of C57BL/6 mice. As illustrated in
Fig. 3C, sexually immature animals (5 and 7 weeks), which are
characterized by low circulating levels of steroid hormones,
and fully mature mice (
13 weeks) show similar amounts of
the AOH2 protein. Surprisingly, the HGs of 9-week-old males
synthesize almost three times less AOH2 than females. Thus,
there is a narrow temporal window during the postnatal devel-
opment of the HG, in which AOH2 acts as a sexually dimor-
phic protein. Interestingly, maximal secretion of androgens is
observed around the ninth week (31), a time which normally
marks full sexual maturity of the male mouse. To assess
whether androgens may be involved in the regulation of AOH2
synthesis, 6-week-old females were treated with testosterone
for 2 weeks (Fig. 3D). Testosterone administration results in
an approximately twofold reduction in the steady-state levels
of the HG’s AOH2 protein. This is the opposite to what ob-
served in the case of hepatic AOX1 (36) and AOH1 (Fig. 3D),
which are dramatically induced by the androgen.
Purification and biochemical characterization of the AOH2
protein from the HG. As a first step in the biochemical char-
acterization of the AOH2 protein, we purified the enzyme to
homogeneity from the HG. The recovery of purified AOH2 is
approximately 5% with a purification factor of approximately
350-fold (Table 1). Both parameters compare well with the
yield and purity of other catalytically active mammalian mo-
lybdoflavoenzymes (37, 67). Highly purified preparations of
AOH2 consist of a single and symmetrical protein peak co-
eluting with anti-AOH2 immunoreactivity (Fig. 4A). The mo-
nomeric subunit of purified AOH2 consists of a single protein
band with an apparent molecular mass of 150 kDa (Fig. 4B). A
further characterization of AOH2 by MALDI-TOF analysis of
the trypsin hydrolysate obtained from the purified protein is
shown in Fig. 4C. As expected from the sequence data of the
corresponding cDNA (36, 37, 67), the tryptic fingerprints of
purified AOH2, AOX1, AOH1, and AOH3 are completely
different. Comparison of the masses obtained experimentally
and predicted from the open reading frame of the AOH2
cDNA allowed us to identify 73 tryptic peptides with a 59.6%
sequence coverage of the AOH2 protein (see Table S2 in the
supplemental material). Spectroscopic analysis of purified
AOH2 shows the typical profile of a molybdoflavoenzyme
characterized by a broad maximum of around 450 nm (Fig.
4D). The spectrum of AOH2 and that of purified mouse liver
AOH1, which is shown for comparison, are indistinguishable.
Studies performed on purified AOH2 indicate that the en-
zyme is capable of oxidizing some of the exogenous substrates
recognized by other mammalian AOXs (data not shown). As
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to endogenous substrates, a major difference between AOH2
and other AOXs is the inability to recognize the vitamin B1
precursor, pyridoxal. Lack of oxidizing activity is observed at
two substrate concentrations that are metabolized effectively
by the same amount of purified mouse liver AOH1 (see Fig.
S1A in the supplemental material). Similar to what was ob-
served for AOH1, purified AOH2 oxidizes RAL into ATRA
(see Fig. S1B in the supplemental material). The enzymatic
FIG. 3. Strain differences and hormonal regulation of AOH2. (A) Cytosolic extracts of HG were prepared from the indicated mouse strains
and subjected to Western blot analysis (100 g of proteins) using anti-AOH2 and anti--actin antibodies. (B) Cytosolic fractions of skin derived
from the indicated mouse strains were treated at 55°C for 10 min and centrifuged to eliminate precipitated proteins. The supernatant was
precipitated with 50% ammonium sulfate to enrich for AOH2. Concentrated extracts (100 g of proteins) were subjected to Western blot analysis
as in the left panel. C, extracts of HEK293 cells transfected with the full-length AOH2 cDNA used as a positive control of the experiment.
(C) Cytosolic fractions were prepared from the HGs isolated from individual animals of the indicated ages and sexes (male [ ] and female []).
The extracts (50 g of proteins) were subjected to Western blot analysis as for panel A. (Top) Bar graph summarizing the results obtained by
densitometric analysis of all the blots; (middle) representative results obtained for 9-week-old animals; (bottom), for comparative reasons, typical
results of a Western blot analysis conducted with anti-AOH1 antibodies in liver extracts are shown. **, significantly lower than the corresponding
group of female animals (Student’s t test; P  0.01; n 	 3). (D) Cytosolic extracts (50 g) of the HG and liver derived from individual female
animals treated with vehicle or testosterone propionate (Ts) were subjected to Western blot analysis with anti-AOH2 (HG), anti-AOH1 (liver),
and anti--actin antibodies. The graphs summarize the results obtained by densitometric analysis of the blots illustrated. **, Significantly lower
(HG) or higher (liver) than the corresponding vehicle-treated group (Student’s t test; P  0.01; n 	 3). M, molecular mass.
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reaction follows classic Michaelis-Menten kinetics (see Fig.
S1C in the supplemental material), and the calculated Km and
Vmax values of AOH2 are 4.8 M and 0.06 mol/min/mg of
protein, respectively. These values are comparable with those
calculated for AOX1 and AOH1 (66, 70). Our results demon-
strate that RAL is an excellent substrate for all the members of
the mouse AOX family.
Generation and characterization of animals with knockout
of the Aoh2 gene. To gain insights into the physiological func-
tion of AOH2, a specific knockout mouse (Aoh2/) was gen-
erated. To delete the gene, a plasmid construct targeting exon
22 of the mouse Aoh2 gene was introduced into ES cells (Fig.
5A). Aoh2/ founder mice were identified in the F1 progeny
by genotyping and subsequently mated to obtain homozygous
animals. The Southern blot analysis performed with 5 and 3
probes confirmed the specific targeting of Aoh2 (Fig. 5B and
Fig. C). The first generation of Aoh2/ animals was obtained
by microinjection of 129/Sv-derived ES cells into BDF1-de-
rived blastocysts (BDF1 mice are an F1 hybrid of C57BL/6 and
DBA/2 mice), and the line was initially expanded in the same
strain of mice. As described above, such a mixed genetic back-
ground was inappropriate for our studies on AOH2. For this
reason, we rederived the Aoh2/ heterozygous founders into
the C57BL/6 background by nine consecutive backcrosses. The
ninth-generation animals have a highly homogeneous C57BL/6
background, as assessed by microsatellite analysis (data not
shown), and were used for all the subsequent studies.
Deletion of Aoh2 exon 22 results in the disappearance of the
corresponding transcript from the HGs of Aoh2/ animals, as
demonstrated by Northern blot analysis, by use of a full-length
cDNA and an exon 22-specific probe (Fig. 5D). In the same
experimental conditions, heterozygotes were characterized by
an approximately 50% reduction in the levels of the AOH2
transcript, while the HGs and skin of homozygous knockout
mice did not produce any AOH2 transcript or protein (Fig. 5E
and F).
In spite of a complete lack of the molybdoflavoenzyme in
target organs and tissues, Aoh2/ animals do not show any
macroscopic, structural, functional, or behavioral abnormality
compared with the corresponding heterozygous and WT coun-
terparts. The growth curves of Aoh2/, Aoh2/, and WT
animals are superimposable. The frequency of the defective
allele transmission is almost Mendelian. Heterozygous mating
resulted in the birth of 839 siblings, with 21% Aoh2/, 52%
Aoh2/, and 27% WT animals. The frequency of knockout
mice in the progeny was slightly below the expected 25% (P 
0.05 after chi-square test), and the corresponding allele fre-
quency in the population was lower than the expected 50%,
suggesting a minor survival disadvantage of the animals carry-
ing the mutated Aoh2 trait. The numbers of female (424
[51%]) and male (415 [49%]) animals were not significantly
different, indicating lack of sex biases.
Subtle alterations in the global gene expression profile of
the Aoh2/ HG: effect of sex and age. The functional devel-
opment of HGs occurs predominantly after birth and is sexu-
ally dimorphic in terms of structure, biochemistry, and function
(15). With this in mind, we sought for organ abnormalities in
Aoh2/ mice of both genders. Although AOH2 is controlled
by testosterone during a defined period of the HG postnatal
development (Fig. 3C), the protein does not seem to play a
significant role in shaping the architecture of the gland in
either male or female mice. As expected, adult C57BL/6 WT
males were characterized by HGs slightly heavier and larger
than those of females. However, the glands of Aoh2/ and
WT male or female animals do not show any difference in
microscopic appearance.
Seeking perturbations of specific biochemical pathways and
cellular processes caused by the absence of AOH2, we com-
pared the global gene expression profiles in the HGs of WT
and Aoh2/ male and female animals before and after sexual
maturation. Two-way ANOVA of the microarray intensity data
with AOH2 deletion used as the first factor and the four
experimental groups as the second one resulted in the selection
of 3,468 significantly perturbed genes (see Materials and Meth-
ods). PCA of these selected data indicates that there is a
remarkable variation of gene expression in the HGs of WT
animals (Fig. 6A). Our results indicate that age is a primary
determinant of the transcriptome, as indicated by the distance
of the dots. This is in line with the idea that the full functional
development of the gland occurs predominantly after birth
(14). Major differences in the gender-specific complement of
genes expressed in WT animals are observed as well. While sex
and age have a dramatic impact on the variability of gene
expression, the absence of AOH2 has a limited effect.
At the single-gene level, Fig. 6B shows the small number of
genes up- or downregulated by AOH2 deficiency. Significantly,
most of the induced changes are observed in sexually immature
mice. This suggests that AOH2 function is particularly signif-
icant during the maturation of HGs. The vast majority of the
up- or downregulated genes are the same in both immature
female and male animals. Sgpl1 (NM_009163), coding for
sphingosine-1-phosphate lyase, is at the top of the list of up-
regulated genes. Sgpl1 is involved in the degradation of sphin-
gosine-1-phosphate, which regulates the proliferation of mam-
malian cells in a negative fashion (61). Ncaph2 (NM_025795)
and Raf1 (NM_029780) are other genes involved in the control
of cell proliferation that are upregulated in Aoh2/ animals.
The presence of Acsl6 (NM_144823, coding for acyl coenzyme
A synthetase long-chain family member 6) and Elovl1
(NM_019422, coding for elongation of very-long-chain fatty
acids), whose protein products are involved in lipid biosynthe-
sis, is also of interest.
TABLE 1. Purification of AOH2 from HGsa
Stepb Vol(ml)
Protein
amt
(mg)
Activity
(units)
Sp act
(units/mg)
Fold
purification
%
Yield
Ultra 22 409 123.9 0.3 1 100
55°C 22 245 95.3 0.4 1.3 77
PD10 28 112 83.1 0.7 2.3 67
Benz. Seph. 15 0.33 NA NA NA NA
MonoQ 1.4 0.06 6.2 103.8 346 5
a HGs (3.4 g) were isolated, homogenized in 27 ml of buffer, and ultracentri-
fuged to obtain a cytosolic extract, which was processed as indicated. Enzymatic
activity was measured as the ability of the various purification fractions to oxidize
RAL into ATRA. One unit of enzymatic activity is defined as 1 nmol of RAL
oxidized/min. The results are representative of two separate AOH2 preparations.
NA, not applicable.
b Ultra, ultracentrifugation; 55°C, treatment at 55°C; PD10, size exclusion
column; Benz. Seph., benzamidine-Sepharose affinity column chromatography;
MonoQ, MonoQ anion-exchange column chromatography.
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Noticeably, the AOH2 transcript was dramatically down-
regulated by more than eightfold in Aoh2/ animals across all
the experimental conditions considered. To further validate
the results of our analysis, we selected four genes at random
(Spt1, NM_009267; Pip, NM_008843; Myh4, NM_010855; and
Ckmt2, NM_198415) and amplified the corresponding tran-
script by quantitative real-time RT-PCR with the same RNA
preparations used for the microarray experiments. Compari-
son of the intensity data obtained by RT-PCR and microarray
analyses demonstrates an excellent correlation (see Fig. S2A in
the supplemental material).
Gene pathways altered in the HGs of Aoh2/ mice: lipid
homeostasis, cell secretion, and tissue remodeling. Due to the
small effect of AOH2 deletion, in terms of both the number
of affected genes and the changes in intensity, we performed
a pathway analysis (see Materials and Methods). Among the
GO categories showing statistically significant enrichment,
we selected the smallest and most significant gene sets,
FIG. 4. Purification and characterization of the AOH2 protein from HGs. (A) The protein fraction (330 g) purified from benzamidine-
Sepharose was applied on a MonoQ fast protein liquid chromatography column and eluted with a linear gradient of NaCl, as indicated (dashed
line). The column was run at a flow rate of 0.5 ml/min, and 2-ml fractions were collected. An aliquot of each chromatographic fraction was assayed
for AOH2 immunoreactivity by quantitative Western blot analysis, and the corresponding elution profile is indicated by the shaded columns
superimposed over the protein elution profile monitored at 280 nm. The inset shows the results of the Western blot performed on aliquots of the
indicated chromatographic fractions using the anti-AOH2 antibody. Abbreviations: SM, starting material; A.U., arbitrary units. (B) Coomassie blue
protein staining, following polyacrylamide gel electrophoresis (left) or Western blot analysis (right), of the indicated protein preparations obtained
at various steps in the purification procedure are shown. “Crude” indicates supernatant centrifuged at 105,000  g; “55°C” indicates supernatant
following heat treatment at 55°C for 10 min. Abbreviations: amm. sulf., ammonium sulfate precipitate; Benz., eluate from benzamidine-Sepharose
affinity column chromatography; MonoQ, eluate from MonoQ anion-exchange column chromatography; M, molecular mass. (C) AOH2 purified
from the HG was trypsinized and subjected to MALDI-TOF analysis. The fingerprint mass spectra of purified AOH2, AOX1 (from livers of DBA/2
mice), AOH1 (from livers of CD1 mice), and AOH3 (from the nasal mucosae of CD1 mice) are compared. (D) Absorbance spectra of purified
AOH2 and AOH1 in native conditions. O.D., optical density.
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FIG. 5. Generation of Aoh2/ mice. (A) (Top) A schematic representation of the targeting cassette used for homologous recombination is
illustrated below the corresponding region of the Aoh2 gene. The 5-to-3 orientation is from left to right. Exons and introns are represented by
black and white boxes, respectively. In the targeting cassette, the neomycin resistance gene (Neo) is inserted in place of exon 22 and substitutes
the corresponding genomic region of the Aoh2 locus upon homologous recombination. Selected restriction endonuclease sites relevant for the
construction of the targeting vector and the detection of the homologous recombination event are listed. The position of the probes (dashed boxes)
used for the detection of homologous recombination by Southern blotting are also shown. (Bottom) The sizes of the restriction fragments before
and after homologous recombination are schematically represented. (B) The Southern blot analyses of genomic DNA isolated from the ES cell
clone (5E7) showing homologous recombination at the Aoh2 locus and parental ES cell line (WT), with the indicated probes, are compared.
(C) Germ line transmission of the homologous recombination event was confirmed by the Southern blot analysis shown and performed on DNA
isolated from WT (/) and heterozygous (/) and homozygous (/) Aoh2/ animals. (D) Northern blot analysis on total RNA derived from
the HGs of WT (/) and heterozygous (/) and homozygous (/) Aoh2/ animals, with a full-length AOH2 cDNA or an exon 22-specific
probe, as indicated. The blot was rehybridized with GAPDH (glyceraldehyde-3-phosphate dehydrogenase) to ascertain that equal quantities of
RNA were loaded in each lane. (E) Western blot analyses of cytosolic extracts (50 g of protein) obtained from the HG and livers of male WT
(/), heterozygous (/), and homozygous (/) Aoh2 animals. (F) AOH2-enriched skin protein extracts (100 g of protein) obtained as for
Fig. 3A from male ( ) and female () WT (/), heterozygous (/), and homozygous (/) Aoh2 animals were subjected to Western blot
analysis. All the blots were developed following incubation with anti-AOH2 and anti--actin antibodies. M, molecular mass.
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reducing the redundancy which is inherent to the GO an-
notation (Table 2).
Ablation of the Aoh2 gene results in a significant enrichment
of pathways controlling two of the main functions exerted by
the gland, i.e., lipid synthesis/catabolism (GO:0008610; GO:
0016042) and cellular absorption/secretion (GO:0016192; GO:
0045045; GO:0006897 GO:0048193). In the context of cellular
secretion, besides pathways controlling endocytosis and Golgi
vesicle transport, the presence of the pathway ATPase activity
(GO:0016887), consisting predominantly of genes encoding
ATP-dependent ATP-binding cassette (ABC) transporters, is
of particular relevance. In fact, human AOX1 has been re-
cently demonstrated to interact specifically with a member of
the ABC transporter family (64). Given the structural similar-
ity with AOX1, it is possible that AOH2 is also capable of
interacting with one or more ABC transporters. Suppression of
this interaction in the HGs of Aoh2/ animals may cause the
observed reorientation of the ATPase activity pathway in an
attempt to compensate for the deficit. Given the role exerted
by the ABC transporters and AOX1 (72) in the absorption/
secretion of lipids, this may be linked to the observed pertur-
bations in the lipid biosynthetic pathways.
AOH2 deletion also seems to have a major impact on the
process of tissue remodeling. In fact, a first large group of
interconnected pathways significantly enriched in Aoh2/ an-
imals controls cell proliferation and cell death/survival (GO:
0008285, GO:0000082, GO:0043065, GO:00443069, and GO:
0008637). This may be linked to the enrichment of stress-
response pathways (GO:0006974, GO:0009611, GO:0006800),
including ubiquitin-dependent proteolysis (GO:0006511) and
maintenance of chromatin architecture (GO:0006325). A sec-
ond group of enriched pathways control cell-cell and cell-ma-
trix adhesion (GO:0007160 and GO:0007229), cell projection
(GO:0042995), and cell migration (GO:0016477), and these
pathways are also linked to tissue remodeling. All these path-
ways are known to control the homeostasis of the cytoskeleton.
Thus, it may not be surprising that group of genes controlling
actin polymerization/organization (GO:0030036) and microtu-
bule assembly (GO:0000226) are also affected by Aoh2 dele-
tion. Perturbations in the gene networks involved in general
cellular processes such as the regulation of transcription
(GO:0045892, GO:0045893), nuclear mRNA splicing (GO:
0000398), glucose catabolism (GO:0006007), or protein trans-
lation (GO:0006413) may simply reflect nonspecific responses
to tissue- and cell-remodeling clues. Our analysis indicates also
perturbation of specific signal transduction systems controlling
the proliferation/apoptosis of epithelial cells, such as the Wnt
and Rho pathways (GO:0016055, GO:0007266).
RAL-oxidizing activity in the Aoh2/ animal: role of AOH2
in the HG and skin. RAL, the precursor of ATRA, the vitamin
A active metabolite, is an excellent substrate for purified
AOH2 (see Fig. S1B and S1C in the supplemental material).
Thus, we deemed it interesting to evaluate whether AOH2 is a
significant modulator of the vitamin A system in the HG and to
conduct similar studies for the skin. RAL is a potential sub-
strate of AOH2 but is also a recognized substrate of at least
three RAL dehydrogenases (RALDHs) known as Raldh1,
Raldh2, and Raldh3 (45). Like AOH2, RALDHs are cytosolic
enzymes; however, unlike AOXs, they require NAD as a
cofactor in the oxidation of RAL into ATRA (43).
As a first approach, we determined the level of RAL-oxidiz-
ing activity in extracts of the HGs from WT and Aoh2/
animals. Cytosolic fractions were first depleted of NAD on
size exclusion columns. Subsequently, these fractions were in-
FIG. 6. Alterations in the transcriptome of the HGs: effects of age,
sex, and Aoh2 deletion. The gene expression data obtained with the
use of whole-genome microarrays were analyzed after stratification for
sex, age, and Aoh2 deletion. (A) The PCA of the VSN intensity values
(means centered) of the 3,468 genes that were significant for any of the
factors (Aoh2/ versus WT, age/sex groups, or interaction) after two-
way ANOVA in the eight experimental groups. Comp, component.
(B) Genes that were most significantly affected by AOH2 deletion (P
0.001 for the “knockout” (KO) factor after two-way ANOVA and
2-fold change in at least one of the four groups). Genes and samples
were clustered using Euclidean distance and average linkage. Accord-
ing to PCA, young animals cluster together, and show similar changes,
while minimal changes are apparent in mature animals. Symbols: ,
male; , female. Abbreviations: a, adult; y, young.
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TABLE 2. GO categories significantly perturbed in HGs and skin of Aoh2/ micea
GO ID Description
No. of: HG Skin
Probes Genes P value Direction P value Direction
GO:0030036 Actin cytoskeleton organization and biogenesis 191 89 1.00E–13 5.71E–06 UP
GO:0000226 Microtubule cytoskeleton organization and biogenesis 54 30 1.00E–13 UP
GO:0007017 Microtubule-based process 239 116 2.36E–05 UP
GO:0016459 Myosin complex 88 42 1.00E–13 DN
GO:0007517 Muscle development 124 60 1.75E–07 DN
GO:0016311 Dephosphorylation 232 108 1.00E–13 UP 5.06E–08 UP
GO:0007243 Protein kinase cascade 112 65 1.00E–13 DN 1.40E–05 UP
GO:0006469 Negative regulation of protein kinase activity 35 18 1.00E–12 DN
GO:0007266 Rho protein signal transduction 122 54 1.00E–13 2.47E–05 UP
GO:0016055 Wnt receptor signaling pathway 174 100 6.58E–06 DN 1.31E–04 UP
GO:0006511 Ubiquitin-dependent protein catabolic process 213 98 1.00E–13 UP 7.46E–07 UP
GO:0006457 Protein folding 362 198 1.00E–13 UP 3.24E–09 UP
GO:0009072 Aromatic amino acid family metabolic process 16 13 1.00E–12
GO:0042136 Neurotransmitter biosynthetic process 16 11 1.00E–12
GO:0008610 Lipid biosynthetic process 153 94 1.00E–13
GO:0016042 Lipid catabolic process 83 56 7.40E–10 DN
GO:0016192 Vesicle-mediated transport 379 187 1.00E–13 UP 5.21E–10 UP
GO:0045045 Secretory pathway 215 101 2.60E–12 UP 3.63E–07 UP
GO:0006897 Endocytosis 212 112 1.00E–13 9.74E–07 UP
GO:0048193 Golgi vesicle transport 128 63 2.28E–11 UP 2.23E–06 UP
GO:0007160 Cell-matrix adhesion 88 49 1.42E–08 DN
GO:0007229 Integrin-mediated signaling pathway 149 74 3.44E–05 DN
GO:0042995 Cell projection 272 127 1.00E–13 UP 1.74E–06 UP
GO:0016477 Cell migration 348 174 1.00E–13 1.30E–05 UP
GO:0001525 Angiogenesis 155 87 2.83E–12 DN
GO:0030890 Positive regulation of B-cell proliferation 16 9 1.00E–12 DN
GO:0050871 Positive regulation of B-cell activation 26 15 1.00E–12 DN
GO:0050671 Positive regulation of lymphocyte proliferation 31 17 1.00E–12 DN
GO:0007050 Cell cycle arrest 59 30 1.00E–12 DN
GO:0008285 Negative regulation of cell proliferation 124 70 1.99E–10 UP 1.82E–12 UP
GO:0000082 G1/S transition of mitotic cell cycle 47 23 1.60E–04
GO:0043065 Positive regulation of apoptosis 163 84 6.21E–09 DN
GO:0043068 Positive regulation of programmed cell death 73 34 1.00E–12 UP
GO:0043069 Negative regulation of programmed cell death 75 36 1.54E–13 UP 4.21E–10 UP
GO:0008637 Apoptotic mitochondrial changes 28 15 1.00E–13 DN
GO:0006325 Maintenance of chromatin architecture 254 111 1.00E–13 UP 2.60E–10 UP
GO:0045893 Positive regulation of transcription, DNA dependent 308 168 1.00E–13 UP 1.24E–05 UP
GO:0045892 Negative regulation of transcription, DNA dependent 246 134 3.13E–12 DN 1.37E–08 UP
GO:0006413 Translational initiation 85 38 1.00E–13 UP 2.69E–05 UP
GO:0000398 Nuclear mRNA splicing, via spliceosome 229 117 1.00E–13 UP 5.93E–08
GO:0007283 Spermatogenesis 192 108 7.03E–06 UP
GO:0048534 Hematopoietic or lymphoid organ development 75 42 6.53E–05 UP
GO:0006974 Response to DNA damage stimulus 294 159 8.44E–10 UP 1.00E–12
GO:0009611 Response to wounding 164 109 2.29E–04 UP
GO:0009411 Response to UV 19 11 1.00E–12
GO:0006800 Oxygen and reactive oxygen species metabolic
process
58 43 3.12E–04
GO:0015992 Proton transport 85 49 5.11E–05 UP
GO:0006007 Glucose catabolic process 78 45 9.56E–10 UP
GO:0019885 Antigen processing and presentation via MHC
class Ib
21 11 3.20E–04
GO:0030216 Keratinocyte differentiation 21 11 3.20E–04 UP
GO:0016757 Transferase activity, transferring glycosyl groups 291 173 1.00E–13 DN
GO:0004497 Mono-oxygenase activity 153 102 1.00E–13
GO:0008146 Sulfotransferase activity 57 39 8.75E–03 DN
GO:0015291 Porter activity 259 156 1.96E–10 DN
GO:0020037 Heme binding 164 106 1.00E–13
GO:0008168 Methyltransferase activity 220 126 8.27E–09 1.15E–09 UP
GO:0016712 Oxidoreductase activity, reduced flavin or
flavoprotein
51 33 3.48E–11 DN
GO:0016714 Oxidoreductase activity, reduced pteridine 7 6 1.00E–12
GO:0016887 ATPase activity 147 72 1.00E–13 UP 7.17E–05 UP
a Following GSEA, we obtained two lists (HG and skin) of categories showing P values of less than 0.001 that were further reduced to eliminate redundancy, as
detailed in Materials and Methods. Boldface indicates cases where the same pathways are enriched in both HGs and skin. In the case of the HG, up- or downregulation
of the pathways was first determined in each of the four experimental groups (male and female; young and adult). The overall direction was considered as upregulation
(UP) if the number of groups showing upregulation exceeded the number of groups characterized by downregulation. The opposite is true in the case of a
downregulation (DN) notation.
b MHC, major histocompatibility complex.
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cubated with RAL before and after readdition of the nicotin-
amide cofactor (Fig. 7A). We used liver extracts, which do not
contain AOH2, as a comparison for our studies. In the HGs of
WT animals, almost all the cytosolic RAL-oxidizing activity did
not require NAD and was due to AOH2. In fact, RAL-
oxidizing activity was at the limit of detection in both NAD-
depleted and NAD-repleted cytosolic extracts from the HGs
of Aoh2/ mice. Similar results were obtained with a conven-
tional HPLC methodol (Fig. 7A) and a sensitive MS method
(data not shown).
The same methodological approach was used for skin cyto-
solic extracts. In the absence of NAD, this tissue contains
RAL-metabolizing activity approximately sevenfold lower than
that seen for the HG, and the enzymatic activity can be mea-
sured only by MS. The readdition of NAD causes an approx-
imate and consistent 20% increase in RAL-oxidizing activity.
This indicates that approximately 80% of the RAL trans-
formed into ATRA is due to NAD-independent RAL oxi-
dase(s). However, only 20% of this NAD-independent activ-
ity, which amounts to approximately 1 to 1.5 pmol/min/mg of
protein, is due to AOH2, as indicated by the results obtained
with the skin of Aoh2/ mice. The remaining activity is likely
to be contributed by the AOX1 isoenzyme, as determined for
the skin by Western blot analysis (Fig. 8A).
The liver is the tissue that contains the highest levels of
RAL-oxidizing activity by far. Approximately 85% of the total
activity is NAD dependent, indicating that RALDHs contrib-
ute the majority of RAL-oxidizing activity (43). In line with the
absence of AOH2 protein in this organ (Fig. 2), hepatic ex-
tracts of WT and Aoh2/ mice are characterized by similar
amounts and proportions of NAD-dependent and NAD-
independent RAL-metabolizing activity. Our observations in-
dicate that AOH2 is the major RAL-metabolizing activity in
the HG and contributes a significant amount of the same
activity in the skin. The data presented were obtained from
female animals, and similar results were observed for the male
counterparts (data not shown).
We established the relevance of AOH2 for the oxidation of
RAL in the whole organism by using sexually mature WT and
Aoh2/ mice. To this purpose, we set up a sensitive and
specific MS method for the determination of RAL and ATRA.
Figure S3 in the supplemental material contains representative
chromatograms illustrating the amounts of RAL and ATRA in
the HG. As illustrated in Fig. 7B, the glands of Aoh2/ ani-
mals contain significantly lower amounts of ATRA than the
WT counterparts. The absolute amounts of RAL in the HG
are approximately 10-fold lower than the corresponding
ATRA values and often at the detection limits of the assay.
Nevertheless, in the same cohort used for the determination of
RAL, we observed that Aoh2/ animals were characterized
by levels of RAL higher than those seen for WT mice. This is
consistent with a significant role of AOH2 in the oxidation of
RAL into ATRA.
We evaluated whether the observed effect could be gener-
alized to the skin. Even in this second AOH2 target tissue, the
content of ATRA is inferior in Aoh2/ animals compared to
that in WT animals. RAL in this organ is always below the
detection limit. Noticeably, despite significant differences in
the overall contributions of AOH2 to the total RAL-metabo-
lizing activity in the skin and HG, the diminutions of ATRA in
both organs are of the same order of magnitude.
ATRA controls the activity of numerous genes via interac-
tion with specific nuclear receptors, which act as ligand-depen-
dent transcription factors (18). However, only a limited set of
retinoid-responsive genes are established and direct targets
(5). The expression profile of this set of 29 genes was evaluated
in the HGs of WT and Aoh2/ mice by use of the microarray
data set. We assessed the enrichment for the retinoid receptor
signaling pathway in the four experimental groups of young
and adult male or female Aoh2/ animals. PCA demon-
strated a clear separation of the dots corresponding to
Aoh2/ and WT animals regardless of the stratification for
sex and age (Fig. 7C). Relative to the WT counterparts, a
significant downregulation of the entire pathway (P  0.02)
was observed for female mice as well as for sexually mature
Aoh2/ male animals (Fig. 7D). The two genes whose levels
were reduced most significantly in knockout relative to WT
animals are Egr1 (early growth response 1) and the gene for
the ATRA-catabolizing enzyme Cyp26b1 (cytochrome P450 26
b1). The expression of the two genes was evaluated by PCR
analysis of the corresponding transcripts (see Fig. S2B in the
supplemental material). This independent analysis confirmed
the results obtained with the microarrays.
Substantial alterations in the global gene expression profile
of the Aoh2/ skin. Potential alterations in the skin transcrip-
tome of the Aoh2/ mice were studied only for sexually ma-
ture females to avoid variability due to age. The overall effect
of AOH2 deletion in this organ was quantitatively more pro-
nounced than that seen for the HG. As shown in Table 3), the
deletion of AOH2 caused upregulation of a relatively large
number of genes (68 genes were upregulated twofold or more;
P  0.005), while the number of downregulated genes (24
genes were downregulated twofold or more; P  0.005) was
limited. The physiological function of a substantial fraction of
genes (37%) is unknown or ill defined.
The top upregulated gene is Mtap2 (AK048375), which
codes for an uncharacterized microtubule-associated protein.
Second on the list is Rps18 (AK018004), which is an 18S ribo-
somal protein. A substantial increase in two genes involved in
lipid biosynthesis, Elovl7 (NM_029001; elongation of long chain
fatty acids) and Lpgat1 (NM_172266; lysophosphatidylglycerol
acyltransferase 1), is also remarkable. In line with alterations in
the pathways controlling chromatin architecture (GO:0006325;
Table 2) and Wnt signaling (GO:0016055) in both the skin and
HG, the expression of two histone genes, Hist1h2a1 and
Histh2af (NM_178182 and NM_175661), as well as that of
Fzd10 (NM_175284; Wnt frizzled receptor), is augmented two-
to threefold. Upregulation of the Sfn gene (NM_018754; strati-
fin) (34) is interesting, as the protein controls the keratinocyte
proliferation/differentiation switch (56) and may be involved in
the epidermal hypertrophy observed for Aoh2/ mice (see
below). Two genes suggesting that AOH2 deficiency is associ-
ated with alterations of the secretory phenotype not only in the
HG but also in the skin are Fgd1 (NM_008001) and Sft2dr
(XM_484715). FGD1 is a Rho GTPase exchange factor whose
deficit is at the basis of X-linked faciogenital dysplasia (24, 30).
SFT2 is thought to be involved in vesicular transport in the
Golgi compartment (21). Another gene of interest for its po-
tential link to AOXs (64) in the same group is Abcd2
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FIG. 7. AOH2-dependent oxidation of RAL in the HG and skin: effects on RAL/ATRA levels in vivo and gene expression correlates.
(A) Cytosolic extracts were isolated from the indicated tissues of WT and Aoh2/ mice depleted of NAD by use of NAP-5 columns (GE
Healthcare) and used to determine RAL-oxidizing activity in the absence or presence of readded nicotinamide cofactor. Each value is the mean 
standard deviation (SD) for three replicates. **, significantly different according to Student’s t test (P  0.01). The results are representative of
at least two independent experiments performed on tissues from different batches of animals. (B) The amounts of RAL and ATRA were
determined by LC-MS with the indicated tissues of WT and Aoh2/ animals. Each value is the mean  SD for four (RAL and HG) or eight
(ATRA, HG, and skin) individual animals. **, significantly different according to Student’s t test (P  0.01). (C) Gene expression pattern of the
retinoid-dependent genes in the HG. PCA of the VSN intensity values (means centered) in the eight experimental groups. Comp, component.
(D) Heat map of the whole set of genes. The P values (upregulation [UP], downregulation [DN], or general significance in boldface) reported
below the heat map refer to the GSEA, as described in Materials and Methods. This analysis was performed to demonstrate the prevalence of a
decrease in the expression of retinoid-responsive genes (green boxes). Symbols: , male; , female. Abbreviations: a, adult; y, young; KO,
knockout.
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FIG. 8. Induction of AOH2 by UVB irradiation and epidermal hypertrophy in untreated and UVB-treated Aoh2/ mice. Four WT or
Aoh2/ female mice per each experimental group were mock treated (control) or treated by UVB light irradiation on the dorsal area of
the skin for 4 days, as described in Materials and Methods. (A) Skin biopsy samples of similar volumes were obtained from the same dorsal
areas of the skin and homogenized. Homogenates (20 g) were subjected to Western blot analysis with anti-AOH2, anti-AOX1, and
anti--actin antibodies as indicated. Please note that in the Western blot shown, the lack of AOH2 signal in basal conditions is merely due
to the low amount of total protein extract loaded. (B) The bar graph illustrates the results obtained on the thickness of the epidermal layer
of the skin after serial morphometric analysis of the slides (25 fields per animal). **, significantly different (Student’s t test, P  0.01). M,
molecular mass. (C) The micrographs show representative fields of the skin obtained from untreated (control) and UVB-irradiated (UV)
WT or Aoh2/ animals. The magnification of photographs is 200. The right bar graphs show the distribution of the epidermal thicknesses
after stratification in four discrete percentile classes. Each value is the mean  SD for four animals. (D) Gene expression pattern of the tissue
hypertrophy category (128 genes, 255 probes) in the skin. PCA of the VSN intensity values (means centered) in the eight samples. Comp,
component. (E) Heat map of the genes significantly changed by AOH2 deletion (P  0.05). The P values (upregulation[UP], downregu-
lation[DN], or general significance in boldface) reported below the heat map refer to the GSEA, as described in Materials and Methods.
This analysis was performed to demonstrate the prevalence of an increase in the expression of “hypertrophy” genes (reddish box). Symbols:
, female. Abbreviations: a, adult; y, young; KO, knockout.
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TABLE 3. List of genes whose expression is significantly perturbed in the skin of Aoh2/ micea
Gene category Accession no. Gene name logRb P valuec
Downregulated genes AK147421 Acsl6 1.81 1.74E–03
AK050118 Igf1 1.44 4.00E–03
NM_033174 Snurf 1.30 3.24E–03
NM_013744 Zfp354b 1.30 4.83E–03
NM_022881 Rgs18 1.27 2.60E–03
NM_145713 Hist1h1d 1.27 3.99E–03
NM_011935 Esrrg 1.27 7.15E–04
NM_011670 Uchl1 1.23 1.87E–03
AY590892 Dmxl1 1.19 2.02E–03
NM_011994 Abcd2 1.17 1.14E–03
NM_030143 Ddit4l 1.12 3.38E–03
NM_026167 Klhl13 1.08 1.92E–03
NM_009808 Casp12 1.05 4.50E–03
AK029536 Ttc18 1.03 4.98E–03
Downregulated unknown genes NM_172419 9030612E09Rik 1.55 3.27E–03
BC058715 C030002C11Rik 1.39 3.26E–03
XM_126361 5730455P16Rik 1.26 4.22E–03
NM_027564 4921507P07Rik 1.23 4.50E–03
NM_001039244 LOC633640 1.20 2.58E–03
NM_172513 BC049806 1.18 1.26E–03
NM_172392 BC028265 1.18 4.27E–03
AK047247 AK047247 1.15 2.40E–03
XM_914237 LOC638271 1.14 1.65E–03
AK052002 AK052002 1.08 1.84E–03
Upregulated genes AK048375 Mtap2 3.80 8.07E–04
AK089714 AK089714 3.04 1.32E–03
AK018004 Rps18 2.71 3.74E–04
XM_147798 Slc4a7 2.45 1.44E–03
XM_900817 Nrg1 2.08 1.17E–03
NM_010600 Kcnh1 2.04 4.59E–03
AK045806 Erbb2ip 2.04 2.40E–03
NM_175661 Hist1h2af 2.03 2.32E–03
AK086235 Wdr45l 1.98 1.43E–03
AK031473 Polr3f 1.97 3.98E–03
AK090248 Sec63 1.97 2.65E–03
NM_010110 Efnb1 1.86 4.35E–03
AK080436 Hmgn1 1.75 1.36E–03
NM_181820 Tmc4 1.74 4.05E–03
AK172914 Lpgat1 1.67 1.55E–03
NM_178182 Hist1h2ai 1.67 1.52E–03
NM_178085 Rab6ip2 1.63 3.83E–03
XM_132817 Ankrd26 1.58 4.60E–03
AK040105 A430061O12Rik 1.56 1.03E–03
NM_016871 Tomm40 1.51 3.93E–03
TC1469302 TC1469302 1.49 2.49E–03
AK044468 Vps29 1.48 2.53E–03
AK082550 AK082550 1.45 4.52E–03
AK037501 Trpc4ap 1.45 4.38E–03
AK014632 Mrpl38 1.44 5.89E–04
BC006644 Smg6 1.39 3.00E–03
NM_028950 Nsun6 1.39 3.68E–03
XM_484715 Sft2d3 1.36 2.09E–03
AK045956 Krit1 1.35 4.27E–03
NM_011119 Pa2g4 1.33 1.76E–03
AK047982 Rtn4 1.33 1.60E–03
NM_175284 Fzd10 1.28 2.21E–03
NM_172266 Lpgat1 1.27 1.77E–03
TC1414359 TC1414359 1.22 3.88E–03
NM_153787 Bclaf1 1.20 2.87E–03
XM_484715 Sft2d3 1.19 4.93E–03
AK084917 Rad23b 1.12 3.16E–03
NM_008001 Fgd1 1.12 1.86E–03
NM_010792 Mettl1 1.11 1.39E–03
NM_016775 Dnajc5 1.05 1.57E–03
NM_029001 Elovl7 1.05 3.54E–03
NM_009726 Atp7a 1.02 4.27E–03
NM_018754 Sfn 1.01 2.64E–03
NM_027026 Lrrc46 1.00 3.95E–03
Continued on following page
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(NM_011994), which is significantly downregulated and codes
for a transporter protein belonging to the ABC transporter
family.
Gene pathways altered in the skin of Aoh2/ mice: simi-
larities and differences with the HG. The same pathway anal-
ysis performed on the transcriptome of HGs was carried out
with the skin data set (Table 2). In Aoh2/ mice, we looked
for the enrichment of pathways unique to the skin or in com-
mon with the HG. Out of the 59 pathways, 13 are specific for
the skin (22%) and 23 (39%) are common to both. Among the
common pathways, 13 are concordantly upregulated. As to the
first group, we observed significant enrichment and an overall
upregulation of the pathway controlling keratinocyte differen-
tiation (GO:0030216). Overall downregulation of pathways in-
volved in lymphocyte proliferation (GO:0050671), B-cell re-
sponses (GO:0030890; GO:0050871), and antigen presentation
via major histocompatibility complex (GO:0019885) is also ev-
ident. Upregulation of the response to UV (GO:0009411) is of
particular interest for the UV-irradiation-dependent pheno-
type observed in the skin of Aoh2/ mice (see the next sec-
tion).
As to the pathways in common between the skin and HG,
Rho and Wnt signal transduction (GO:0007266, GO:0016055),
vesicular trafficking (GO:0016192, GO:0045045, GO:0006897,
GO:0048193), and ATPase activity (GO:0016887), consisting
predominantly of ABC transporters, are of relevance. Al-
though the observed enrichment of pathways like positive reg-
ulation of programmed cell death (GO:00043068) and micro-
tubule-based process (GO:0007017) are listed as specific to the
skin, they are linked to similar pathways also altered in the HG
(GO:0043065 and GO:0000226). Along with the common
pathways controlling cell projection and migration (GO:
0042995 and GO:0016477), they may reflect tissue-remodeling
processes accompanying epidermal hypertrophy.
Epidermal hypertrophy in the Aoh2/ animal and gene
expression correlates. Subchronic UVB irradiation of the skin
is accompanied by induction of the AOH2 protein in WT
animals (Fig. 8A). Induction is specific to AOH2, as expression
of AOX1, the other AOX present in the skin, is not modified
in the same experimental conditions. In addition, the elevation
of AOH2 is due to direct exposure to UV light, as the levels of
the protein are left unaffected in the HGs of irradiated animals
(data not shown). All this indicates that induction of AOH2 is
part of the response to UV activated in the skin. With this in
mind, we studied the histological appearance of the tissue in
Aoh2/ animals not only under basal conditions but also after
subchronic exposure to UV light. The UV experiments were
also prompted by the microarray results shown in Table 2
indicating enrichment of the UV response pathway in the skin
of Aoh2/ mice.
Serial morphometric analysis of tissue sections obtained for
basal conditions indicates that the overall thickness of the
epidermal layer is significantly augmented in Aoh2/ animals
relative to what was seen for WT animals (Fig. 8B). The mi-
crographs shown illustrate the point in two representative
fields obtained from the dorsal skin (Fig. 8C, left). As the
epidermal layer is heterogeneous and its thickness is position
dependent, we looked at the distribution of the parameter in a
large number of sections. In Aoh2/ animals, we observed a
shift toward the second and third quartiles of the epidermal
thickness distribution (Fig. 8C, right). As expected, UV irra-
diation of WT animals results in a remarkable thickening not
only of the epidermal but also of the dermal component of the
skin (data not shown). A quantitative assessment of the in-
TABLE 3—Continued
Gene category Accession no. Gene name logRb P valuec
Upregulated unknown genes XM_912173 LOC636687 2.83 1.26E–03
BC090402 BC090402 2.30 1.71E–03
AK081758 B930068K11Rik 2.13 3.02E–03
TC1477839 TC1477839 2.13 4.32E–03
TC1522673 TC1522673 1.96 3.32E–03
AK220358 9130404D08Rik 1.79 1.71E–03
BC028769 6030458C11Rik 1.71 3.16E–03
AK084691 AK084691 1.68 4.50E–03
TC1533348 TC1533348 1.65 1.14E–03
AK164650 5530601H04Rik 1.59 1.54E–03
AK014787 4833428M15Rik 1.59 3.48E–03
ENSMUST00000024982 ENSMUST00000024982 1.58 1.27E–03
AK049426 AK049426 1.48 4.37E–03
NM_177271 E130306M17Rik 1.46 4.24E–03
AK081612 9130404D08Rik 1.46 3.08E–03
AK011948 AK011948 1.43 9.84E–04
AK036075 AK036075 1.42 2.90E–03
AK013536 3010026O09Rik 1.38 2.09E–03
NM_027561 4632415L05Rik 1.31 1.31E–03
XM_923365 D430007A19Rik 1.23 3.08E–03
NM_001012326 LOC433762 1.18 1.17E–03
AK049476 C430014M02Rik 1.09 2.81E–03
XM_130548 2610101J03Rik 1.04 3.13E–03
AK079466 A030007N12Rik 1.00 2.67E–03
a List of the genes significantly up- or downregulated in the skin of Aoh2/ mice after analysis of the gene expression microarray results (P  0.05; 
2-fold change).
b logR is the log2 ratio (Aoh2/ versus WT mice) of the mean values for four individual pairs of animals.
c P values indicate the statistical significance of each determination.
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creased thickness of the epidermal layer is shown by the cor-
responding distribution graph. UV radiation-dependent thick-
ening of the epidermis is enhanced in Aoh2/ animals. In fact,
the distribution graph shows a dramatic increase in the number
of sections falling in the upper quartile.
Taken together, these results indicate that AOH2 acts as a
negative modulator of the epidermal trophism. With respect to
this, pathway analysis of the skin microarray data, with the use
of the Metacore “diseases” lists rather than GO categories,
resulted in the discovery of an interesting gene expression
correlate. The top hit after comparison of the Aoh2/ and
WT datasets was the “ tissue hypertrophy” category (128
genes, 255 probes). PCA of the genes contained in this cate-
gory showed a clear separation between the Aoh2/ and WT
experimental samples (Fig. 8D). The heat map of the 29 indi-
vidual genes whose expression is significantly altered as a con-
sequence of AOH2 deletion shows a prevalence of upregulated
genes (Fig. 8E). Most of the genes in the group have been
studied in detail for their significance in myocardial hypertro-
phy. However, they may also exert a similar role in the epider-
mis, as their expression profile based on expressed sequence
tag counts indicate that many of them are represented in the
skin (UniGene resource at NCBI; http://www.ncbi.nlm.nih.gov
/UniGene). Only a limited number of the corresponding pro-
tein products whose expression is significantly altered in
Aoh2/ mice will be considered. Ataxin 7 (Atxn7) coding for
a relatively ubiquitous protein, is at the top of the list of
upregulated genes. Members of the ataxin family have recently
been linked to tissue regeneration and epithelial cell repair in
several organs, including the skin (52). The gene for the 2d
form of calcium-calmodulin-dependent kinase II (CaMKII2d),
a strong inducer of cardiac hypertrophy (19), may control
keratinocyte proliferation and differentiation, which are calcium-
dependent processes. As to thrombospondin 1 (Thbs1), upregu-
lation in Aoh2/ mice may have an indirect role on epidermal
hypertrophy, as the corresponding protein activates transform-
ing growth factors, which are involved in controlling the pro-
liferation of keratinocytes (69). The increase in the focal ad-
hesion kinase gene, Ptk2, may just reflect the augmented
number of keratinocytes in Aoh2/ animals and the corre-
sponding focal adhesions that keep these epithelial cells to-
gether. The transcription factor AP2 alpha (Tcfap2a) is
present in the skin at relatively high levels and has a strong
inductive effect on basal keratin expression (17). The gene for
adrenergic receptor kinase, beta 1 (Adrbk1) regulates not only
the proliferative state of various cell types but also the motility
of epithelial cells (51). The downregulated myostatin gene
(Gdf8) belongs to the transforming growth factor  family and
is a negative regulator of muscle growth (32). Though ex-
pressed at high levels in the muscle and heart, myostatin is also
present in the skin, where it could serve an antiproliferative
effect on keratinocytes as well.
DISCUSSION
The data contained in this report provide novel insights into
the tissue/cell distribution, biochemical characteristics, regula-
tion, and function of AOH2, one of the four AOXs present in
marsupials and rodents but absent from primates and humans
(55). In particular, the generation and characterization of a
constitutive Aoh2 knockout mouse represents an important
first step in the definition of the homeostatic function of the
corresponding protein product, for which no information was
available. The importance of this model is heightened by the
fact that it is the first animal knockout targeting a member of
the AOX family.
The tissue and cell distribution data indicate that by far the
richest source of AOH2 is the HG. In this organ, AOH2 is the
only member of the AOX family present, and it is very abun-
dant, representing around 0.25% of all the cytosolic proteins.
AOH2 is expressed by the main population of the secretory
cells (14–16). Significant amounts of AOH2 are also evident in
two prominent structures of the skin, i.e., the sebaceous glands
and the suprabasal layer of the epidermis. The epidermis is not
the sole keratinized epithelium where AOH2 is synthesized, as
the protein is also present in the epithelial lining of the oral
cavity, the esophagus, and the distal portion of the stomach
(68).
AOH2 and the HG. The observation that mouse HGs are
rich in AOH2 suggests that the enzyme exerts an important
function in these structures. This organ-specific function must
have become as dispensable as the entire gland in primates and
humans (55), providing a simple explanation as to why the
Aoh2 orthologous gene was deleted from these two species.
The HG develops predominantly after birth, becomes func-
tionally mature in the adult, and is characterized by sexually
dimorphic structural and biochemical traits (14–16). Different
functions have been ascribed to the gland, such as lubrication
and protection of the eye surface, control of the circadian
rhythm, innate immunity, and the synthesis or secretion of
pheromones regulating the sexual and social behavior of ani-
mals.
At present, the phenotypic studies conducted in Aoh2/
mice do not provide any evidence for a role of AOH2 in the
HG related to a protective effect on the eye. Indeed, the
knockout mice do not show any sign of acute or chronic patho-
logical alterations of the cornea or sclera. Similarly, behavioral
studies aimed at evaluating an involvement of AOH2 in the
control of circadian rhythm were substantially negative (Terao,
unpublished). Incidentally, this observation suggests that
AOH2 deficiency does not impinge on the synthesis of mela-
tonin and porphyrins, which are the two main types of sub-
stances synthesized by the HGs and are purported to be in-
volved in the control of circadian rhythm (14). At the
transcriptomic level, this is supported by lack of perturbations
in the expression of genes participating in the biosynthetic/
catabolic pathways of melatonin or porphyrins. Though ad hoc
studies on mating and social behaviors have not been con-
ducted, observations of Aoh2/ animals have been against a
role for AOH2 in these two types of activity largely controlled
by pheromones. Obviously, our animal colonies are bred and
maintained in standard-pathogen-free animal house facilities
under standard conditions. Thus, our observations do not rule
out the possible relevance of the enzyme in the synthesis/
catabolism or secretion/absorption of pheromones by the HG
when the animals are exposed to stronger environmental stim-
uli. The transcriptome profiling experiments and subsequent
pathway analyses indicate that the major perturbations af-
forded by Aoh2 deletion are observed in young animals, sug-
gesting that AOH2 is implicated predominantly in the struc-
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tural and functional maturation of the gland. Interestingly, our
microarray data suggest that the transcriptome of young fe-
males is affected by Aoh2 deletion more significantly than is the
male counterpart. This may be linked to the observed negative
effect of endogenous testosterone on AOH2 expression (Fig.
3C and D). In the adult, the function of AOH2 may become
more restricted, with more subtle overall consequences in
terms of transcriptome perturbations. At least partially, this
may be the result of unidentified compensatory mechanisms,
which, however, do not include transcriptional activation of the
genes coding for other aldehyde isoenzymatic forms (data not
shown).
A potential mediator of the effects exerted by AOH2 in both
immature and mature mice is ATRA. In fact, RAL, the phys-
iological precursor of ATRA, is an excellent substrate of pu-
rified AOH2. Furthermore, AOH2 is responsible for the ma-
jority of the HGs’ enzymatic activity transforming RAL into
ATRA. In this site, AOH2 seems to be much more important
than RALDHs (Raldh1, Raldh2, and Raldh3) in the synthesis
of ATRA from RAL (45). Finally, the HGs of Aoh2/ mice
are characterized by increases in the basal levels of RAL and
a corresponding decrease in the amounts of ATRA. All this is
consistent with a role for AOH2 in regulating the local synthe-
sis of ATRA. Although the quantitative reduction of ATRA in
the HGs of knockout animals is approximately twofold, the
effect is likely to be of physiological relevance, as it is accom-
panied by a significant overall downregulation of the small
group of genes, which are established and direct retinoid tar-
gets (5).
How do alterations in the local levels of ATRA or possibly
RAL relate to the suggested changes in the development and
transcriptomic profile of the HG observed for Aoh2/ ani-
mals? ATRA is a well-known morphogen controlling the de-
velopment of multiple organs and systems in the embryo. This
may explain why the major perturbations in the transcriptome
afforded by Aoh2 deletion are observed in sexually immature
animals of both sexes. The phenomenon may be related to a
potential role of AOH2 in the postnatal development of the
HG via control of ATRA in a spatially and temporally re-
stricted fashion. Interestingly, Raldh3 knockout mice show
atresia of the HG (22), demonstrating that the enzyme is im-
portant for the genesis of this organ in the embryo. We pro-
pose that AOH2 takes the place of Raldh3 after birth. Besides
its developmental effects, ATRA is particularly important in
the control of epithelial cells’ homeostasis and is a purported
modulator of HGs’ function (74). In addition, the HG is a
major deposit of ATRA after administration of the radioactive
compound to vitamin A-deficient mice (75). Alterations in
pathways controlling cell proliferation and death/survival, tran-
scription/translation, chromatin structure, and cytoskeletal or-
ganization may simply reflect a tissue-remodeling effect due to
perturbations of local and AOH2-dependent ATRA synthesis.
In this context, the enrichment of the Wnt/-catenin pathway
is of relevance, as ATRA is known to exert numerous modu-
lating effects on this signal transduction system (26, 27).
There is support in the literature for the possible influence
that ATRA or RAL has on vital and specific functions of the
HG’s epithelial cells, like cellular secretion and lipid ho-
meostasis (3). As to the first aspect, the literature is rich in
studies on the role exerted by retinoids on the function of
exocrine glands and sebaceous glands in particular (58, 73).
With respect to lipids, ATRA has been recently shown to
activate not only the classic rexinoid/retinoic acid receptors but
also peroxisome proliferator-activated receptors / (20, 59,
60, 63), which are major positive regulators of lipid/cholesterol
biosynthesis and accumulation (62). There is increasing evi-
dence that RAL is not simply a precursor of ATRA but is on
its own an important negative modulator of lipid biosynthesis
and adipocyte differentiation (76, 77). No matter whether
ATRA or RAL forms the basis of the perturbations in lipid
homeostasis-controlling genes observed for Aoh2/ mice, the
expected net result would be the same, i.e., an antilipidemic or
anticholesterolemic effect. In line with this expectation, pre-
liminary experiments demonstrate a decrease in the amounts
of cholesterol extracted from the HGs of Aoh2/ animals
(Terao, unpublished observations, 2008).
AOH2 and the skin. In the skin, AOH2 is synthesized by two
main structures, the sebaceous glands, which are located in the
dermis, and the suprabasal layer of the epidermis. Sebaceous
glands and HGs share many similarities. They are both exo-
crine glands, producing a lipid-rich secretion; have similar se-
cretory modalities; are involved in the production/secretion of
pheromones; and accumulate significant amounts of retinoids
(39). Sebaceous glands and the epidermis cooperate in provid-
ing a lipid-containing barrier to the penetration of environ-
mental chemicals by limiting their diffusion to the skin (40). In
addition, the suprabasal layer of epidermis and the sebaceous
gland contain the highest levels of retinoids in the skin (1).
As already discussed in the case of the HG, a fundamental
question strictly related to the function of AOH2 in sebaceous
glands and epidermis is why the enzyme became obsolete in
primates and humans. Indeed, the two skin structures are con-
served in rodents, primates, and humans. One possible and
partial answer relates to the fact that mammalian sebaceous
glands are known to control thermoregulation via secretion of
thermally insulating lipids (incidentally, the same is proposed
for the HG). This function in humans is essentially different
from that in other mammals, which are adapted to respond
much more promptly to environmental changes of tempera-
ture. It may be envisaged that AOH2 serves a role in the rapid
activation/inactivation of chemical signals or hormones con-
trolling the secretion of lipids. The human organism may have
evolved different chemical mediators that are no longer sub-
strates of AOH2. Another and more comprehensive answer
stems from our observation that AOH2 is not the only AOX
present in the skin, as the expression of AOX1 is also evident
(Fig. 8A). AOX1 is the only active AOX present in primates
and humans, and there is evidence for the expression of the
corresponding gene in human skin (UniGene Hs.406238). Hu-
man and mouse AOX1 proteins share common substrates with
AOH2, including RAL (Terao, unpublished results, 2008).
Thus, it is possible that the rodent skin is a more robust system
than the primate/human counterpart and requires redundancy
in AOXs. In humans and primates, it is possible that a single
AOX is enough. Interestingly, we showed that AOH2 is induc-
ible upon application of external stimuli like UV, while AOX1
is not, suggesting that the function exerted by the former pro-
tein is particularly important in stressful conditions.
In spite of a low overall level of AOH2 expression, skin is
presently the only organ of Aoh2/ mice characterized by a
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morphologically recognizable alteration in the phenotype. In-
creased thickness of the Aoh2/ epidermis is maintained after
exposure to UV light, an external stimulus inducing an epider-
mal hypertrophic response on its own. Analysis of the skin
transcriptome of Aoh2/ animals is consistent with the ob-
served phenotype and shows a number of significant alter-
ations in general pathways controlling cell proliferation, death/
survival, motility, cytoskeletal structure, tissue remodeling,
and, finally, hypertrophy. This is accompanied by perturbations
of additional specific and relevant pathways like keratinocyte
differentiation, Wnt signaling, and response to UV. Interest-
ingly, keratinocyte differentiation and response to UV are
pathways specifically enriched in the skin relative to the HG.
As in the case of the HG, is it possible to link the morpho-
logical and transcriptomic alterations observed for the
Aoh2/ mice with the reported influence of AOH2 on the
levels of ATRA in the skin? Measurement of ATRA levels in
Aoh2/ mice indicates a role for AOH2 in the homeostasis of
vitamin A in the skin, although the enzyme’s contribution to
total RAL-oxidizing activity is lower in this organ than in the
HG. It is well known that vitamin A deficiency is associated
with extensive proliferation of epithelial cells in various organs,
including the skin. The epidermal hypertrophy of Aoh2/
animals is also reminiscent of that observed for a line of trans-
genic animals characterized by the expression of a dominant
negative form of the retinoid receptor, RAR (4). This last
animal model is characterized by hyperkeratosis and scaling in
addition to skin lipid dystrophy. Hence, our findings are con-
sistent with the concept that Aoh2 deletion causes local ATRA
deficiency and the ensuing epidermal hypertrophy.
At present, it is not possible to know whether the observed
effect on the epidermis is the result of a direct action on
keratinocytes caused by retinoid deficiency or if more-complex
underlying mechanisms are operative. In fact, the action of
ATRA on the growth and trophism of epidermal keratinocytes
is controversial. ATRA inhibits the growth of keratinocytes in
vitro, while the external application of high doses of retinoids
seems to have the opposite effect in vivo (23, 57). For instance,
it is entirely possible that epidermal hypertrophy is a secondary
response to alteration in the homeostasis of the immune sys-
tem triggered by local ATRA deficiency, as suggested by path-
way analysis of the microarray data. ATRA is a well-known
modulator of the immune system, and alteration of the ho-
meostasis of the skin immune responses could influence the
growth of the epidermal layer, altering the balance of cytokines
and growth factors secreted by lymphocytes and/or macro-
phages (1).
Retinoid-related versus -unrelated functions of AOH2. In
conclusion, many of the data obtained in the knockout model
described in this report are consistent with a significant role of
AOH2 in the local synthesis and biodisposition of endogenous
retinoids in the HG and skin. If this is indeed the case, it must
be emphasized that the role of AOH2 is not systemic and is
limited to a few target organs and to the adult organism. This
is in line with a multimodal and complex control of the ho-
meostasis of endogenous retinoids. In this scenario, Raldh1,
Raldh2, and Raldh3 are certainly more important than AOH2
in regulating the systemic levels of endogenous retinoids and
the function of vitamin A in organogenesis and embryo devel-
opment. The significance of AOH2 for retinoid homeostasis
does not rule out functions and substrates other than RAL for
AOH2. AOH2 may protect the skin and the body via metab-
olism of harmful exogenous compounds. The hypothesis will
be easy to test in vivo by determining the sensitivity of our
knockout animals to selected environmental poisons or pollut-
ants. However, a prerequisite for this type of studies is a better
definition of the exogenous substrates of AOH2 to determine
whether the enzyme has the same broad specificity that char-
acterizes other AOXs. In addition, it is possible that some of
these alternative functions may be unrelated to the enzymatic
activity of AOH2, as observed in the case of the other
molybdoflavoenzyme, XOR (71). With respect to this, the
recent reports demonstrating that human AOX1 is capable
of interacting with ABC transporters and is important for
the accumulation of triglycerides through as-yet-undefined
mechanisms (72) are of great relevance for the presence of
AOH2 in both HGs and sebaceous glands.
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